Trials / Completed
CompletedNCT03479203
Acute Effects of E-Cigarette Aerosol Inhalation
Acute and Long-term Effects of E-Cigarette Aerosol Inhalation on Biomarkers of Endothelial Function and Vascular Reactivity
- Status
- Completed
- Phase
- EARLY_Phase 1
- Study type
- Interventional
- Enrollment
- 31 (actual)
- Sponsor
- University of Pennsylvania · Academic / Other
- Sex
- All
- Age
- 18 Years – 35 Years
- Healthy volunteers
- Accepted
Summary
This study comprises a portion of a larger study designed to compare results of vascular function in non-smokers to vascular function in healthy smokers chronically exposed to nicotinized electronic cigarette aerosol versus conventional cigarettes.
Detailed description
Here, we 1) investigate the acute effects of non-nicotinized e-cigarette aerosol inhalation in nonsmokers in terms of blood-based markers of inflammation and oxidative stress, and 2) evaluate their association with hemodynamic-metabolic MRI parameters quantifying peripheral vascular reactivity, cerebrovascular reactivity, and aortic stiffness.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Electronic Cigarette Aerosol | 16 two-second-long puffs from a non-nicotinized electronic cigarette. |
Timeline
- Start date
- 2018-05-22
- Primary completion
- 2022-08-31
- Completion
- 2022-08-31
- First posted
- 2018-03-27
- Last updated
- 2024-05-08
- Results posted
- 2024-05-08
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT03479203. Inclusion in this directory is not an endorsement.